Fifty 1 Labs, Inc. Acquires MSK Signal Recovery Product Line to Accelerate Growth in the Peptide and Musculoskeletal Health MarketAcquisition expands Fifty 1 Labs' portfolio with a five-product musculoskeletal recovery platform focused on injury recovery, rehabilitation, connective tissue support, joint health, and peptide-focused research
Fifty 1 Labs Outlines Planned U.S. Telehealth Peptide Services PlatformModel expected to include digital intake, clinician evaluation, prescription routing, monitoring coordination, and subscription-based patient support
Fifty 1 Labs Announces Strategic Evolution into Peptide Biotechnology and TelehealthCompany outlines dual platform spanning peptide R&D, AI-enabled discovery, and planned U.S. telehealth peptide services
